Recarbrio OK’d for complicated urinary tract, intra-abdominal infections

Health Problems

(HealthDay)—The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, the U.S. Food and Drug Administration announced. Recarbrio, a three-drug combination injection, is intended to be used for patients who have limited or no alternative antibacterial drugs to treat their infection, Ed Cox, M.D., […]

Continue reading »

A new way to detect hidden urinary tract infections

Health Problems

Researchers in infection biology have developed a new way to detect hidden urinary tract infections. The research was led by Professor Agneta Richter-Dahlfors, head of the Swedish Medical Nanoscience Center at Karolinska Institutet and published in NPJ Biofilms and Microbiomes. Bacteria can persist in the urinary tract for prolonged periods of time, evading capture by the immune system and avoiding […]

Continue reading »

Cell-free DNA profiling informative way to monitor urinary tract infections

Health Problems

Using shotgun DNA sequencing, Cornell University researchers have demonstrated a new method for monitoring urinary tract infections (UTIs) that surpasses traditional methods in providing valuable information about the dynamics of the infection as well as the patient’s biological response. The technique is detailed in the paper “Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract,” […]

Continue reading »